MAPS Wraps Second Phase 3 Trial of MDMA-Assisted Therapy for PTSD Post published:November 17, 2022 Post category:News/Press Release
BREAKING: Morgan Stanley Publishes Optimistic Report on Psychedelics Post published:August 1, 2022 Post category:News
Inside the Challenge to DEA’s Proposed Scheduling of 5 Psychedelic Tryptamines Post published:July 29, 2022 Post category:Analysis/News
Preparing for COMPASS Pathways’ Phase Data Readout: 2b, or not to be? Post published:November 5, 2021 Post category:Analysis/News
Toronto University Health Network Launches Psychedelic Psychotherapy Research Centre Post published:September 27, 2021 Post category:News
Canadians Overwhelmingly Support Legal Access to Psilocybin-Assisted Therapy, Poll Reveals Post published:August 4, 2021 Post category:News
Harvard Law School’s Petrie-Flom Center Launches Research Initiative on Psychedelics and the Law Post published:June 30, 2021 Post category:Analysis/News
Op-ed: UK Public Support Psilocybin Research & Rescheduling Despite Government Stance Post published:June 4, 2021 Post category:News/Op-ed
Psychedelics and Cannabis ETF Launches on NYSE Arca in First for the U.S. Post published:June 1, 2021 Post category:News